

Dechra Pharmaceuticals said adverse weather and supply issues in the US affected trading in the third quarter. In an update for the year to end of Ju...


Anglo American: Goldman Sachs reduces target price from 1400p to 1100p and retains a sell recommendation. Antofagasta: Goldman Sachs takes target pri...


The FTSE 100 opened higher on Wednesday morning, though gains were only slight as investors turned cautious ahead of a statement from the Federal Rese...


Consumer electronics company CSR climbed into the top spot on Wednesday after it saw profits soar in the first quarter bolstered by strong sales of wi...


Dechra Pharmaceuticals reported an increase in revenue in the first three months of the year as a rise in Europe sales offset a fall in the US. Group...


Afren: Nomura shifts target price from 175p to 180p keeping a neutral rating. ASOS: Nomura increases target price from 2000p to 2630p, while reiterat...


: Panmure Gordon reduces target price from 2159p to 1742p and reiterates its hold recommendation. Antofagasta: JP Morgan cuts target price from 1485p...


Dechra Pharmaceuticals raised its dividend by 15.1 per cent as the company achieved higher revenues and profits during the second half of 2012. The v...